Immune-mediated kidney disease in 2017: Progress in mechanisms and therapy for immunological kidney disease

Nat Rev Nephrol. 2018 Feb;14(2):76-78. doi: 10.1038/nrneph.2017.171. Epub 2017 Dec 18.
No abstract available

Publication types

  • Review

MeSH terms

  • Adrenal Cortex Hormones / adverse effects*
  • Adrenal Cortex Hormones / therapeutic use
  • Animals
  • Antibodies, Antineutrophil Cytoplasmic
  • Autoantigens / genetics
  • Autoimmune Diseases / drug therapy*
  • Autoimmune Diseases / immunology*
  • Budesonide / administration & dosage*
  • Budesonide / adverse effects
  • Complement C5a / antagonists & inhibitors
  • DNA Methylation
  • Drug Delivery Systems
  • Glomerulonephritis, IGA / drug therapy
  • HLA Antigens
  • Humans
  • Kidney Diseases / drug therapy*
  • Kidney Diseases / immunology*

Substances

  • Adrenal Cortex Hormones
  • Antibodies, Antineutrophil Cytoplasmic
  • Autoantigens
  • HLA Antigens
  • Budesonide
  • Complement C5a